Where does Jennewein Biotechnologie GMBH rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Jennewein Biotechnologie GMBH ranks #24,603 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Jennewein Biotechnologie GMBH hold?

Jennewein Biotechnologie GMBH holds 11 US utility patents granted between 2016 and 2021, spanning 11 technology areas.

What is Jennewein Biotechnologie GMBH's Innovation Score?

Jennewein Biotechnologie GMBH has an Innovation Score of 30.1 out of 100 (33rd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Jennewein Biotechnologie GMBH's patent grant rate increasing or decreasing?

Jennewein Biotechnologie GMBH's recent grant velocity is -43% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Jennewein Biotechnologie GMBH's patents?

Jennewein Biotechnologie GMBH's patents average 16.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Jennewein Biotechnologie GMBH patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Jennewein Biotechnologie GMBH

Q: What technology areas does Jennewein Biotechnologie GMBH focus on?

Jennewein Biotechnologie GMBH's top technology area is C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture) with 8 patents, ranking #236 of 1,268 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

USPTO PatentsView assignee record - 11 granted patents across 11 technology areas, recorded in grant years 2016–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Jennewein ranks #24,603 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 11 technology areas.

#24,603
of 49,997 US assignees by volume: 33rd percentile
by Innovation Score (30.1/100): 16.4
avg claims per patent: -43%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R24603 · Foreign Corporation #24,603 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 11 grants
MID-PACK #24,603/49,997
PHOTO-FINISH J Sonic Services
CPC-FOCUS C12P · 11 areas
INNOV-THIN 30.1/100
CLAIMS-RICH 16.4 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -43% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: J. Sonic Services Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Jennewein’s 30.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.6 pts (29%) Velocity 0.0 pts (0%) Breadth 11.7 pts (39%) Claim depth 9.8 pts (33%)

Qualcomm Incorporated · highest

85
Jennewein Biotechnol… · this assignee

30
3D Lighting… · lowest

7

What this shows Jennewein's Innovation Score is 30.1/100 (33rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Jennewein?

Each dot is one of Jennewein’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Jennewein’s own 16.4 claims/patent is ABOVE the 6.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Jennewein vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Jennewein's grants concentrate

Jennewein Biotechnologie GMBH is a focused PatentsView assignee: 11 CPC subclasses with 72.7% of grants classified under C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture). Peak complete grant year is 2021 (4 grants) versus a trough of 1 in 2017. By volume, Jennewein sits between J. Sonic Services Inc. and Jiangsu Advanced Memory Semiconductor Co., Ltd..

J Sonic Services

11
J E T

11
J R Setina Manufa…

11
Jane

11
Jetmax Lighting I…

11
JGR Copa

11
Jheeco E-drive

11
Jiangsu Advanced…

11
Jennewein Biotech… ◀

11

What this shows Jennewein holds 11 patents at rank #24,589, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Jennewein

By rank, the assignees closest to #24,589 in granted patent volume.

Leaders in C12P (Fermentation OR Enzyme-using Processes TO Synthesise A De…)

Other assignees with the most granted patents in Jennewein's primary technology class.

Jennewein's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

30 33rd percentile higher than 33% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Jennewein Biotechnologie GMBH patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	2	18.2%
2017	1	9.1%
2018	2	18.2%
2019	2	18.2%
2021	4	36.4%

Which technologies does Jennewein Biotechnologie GMBH patent most?

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 8

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 6

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 5

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 5

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 5

A23L - Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof 4

A23V - Indexing Scheme Relating TO Foods, Foodstuffs OR Non-alcoholic Beverages AND Lactic OR Propionic Acid Bacteria Used IN Foodstuffs OR Food Preparation 4

Y02A - Technologies FOR Adaptation TO Climate Change 2

C12Y - Enzymes 2

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 2

B01D - Separation 2

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Jennewein Biotechnologie GMBH's patent record in context - here's where to go next.

Jennewein Biotechnologie GMBH's lead technology class is C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture), 72.7% of its portfolio - see every assignee active in that class. Explore C12P
Ranked #24,603 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Jennewein Biotechnologie GMBH against J. Sonic Services Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 30.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.